Colmers William F., El Bahh Bouchaïb
Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada.
Epilepsy Curr. 2003 Mar;3(2):53-58. doi: 10.1111/j.1535-7597.2003.03208.x.
It is a central tenet of the epilepsy field that seizures result from the imbalance of excitation over inhibition (1). The bulk of excitation is mediated by the neurotransmitter glutamate, whereas inhibition results mainly from the actions of gamma-aminobutyric acid (GABA). In the neocortex and hippocampus, the intrinsic sources of GABA are the interneurons, which lately have come under intense scrutiny. It has become clear that a large number of distinct types of interneurons can be differentiated in part by the array of neuropeptides they coexpress (cf. (2)). Evidence is emerging that the neuropeptide complement of interneurons plays important roles in the way that interneurons regulate excitability. Here we discuss what is known about the relation of one well-characterized neuropeptide, neuropeptide Y (NPY), and epilepsy in experimental animals and humans, and suggest possible roles for the receptors as targets for the control of excessive excitation in epilepsy.
癫痫领域的一个核心原则是,癫痫发作源于兴奋与抑制之间的失衡(1)。大部分兴奋由神经递质谷氨酸介导,而抑制主要源于γ-氨基丁酸(GABA)的作用。在新皮层和海马体中,GABA的内在来源是中间神经元,这些中间神经元最近受到了密切关注。很明显,大量不同类型的中间神经元可以部分通过它们共表达的神经肽阵列来区分(参见(2))。越来越多的证据表明,中间神经元的神经肽组成在中间神经元调节兴奋性的方式中起着重要作用。在这里,我们讨论关于一种特征明确的神经肽——神经肽Y(NPY)与实验动物和人类癫痫之间关系的已知情况,并提出受体作为控制癫痫中过度兴奋靶点的可能作用。